British Medical Journal – Influenza: marketing vaccine by marketing disease

Influenza: marketing vaccine by marketing disease

The CDC pledges “To base all public health decisions on the highest quality scientific data, openly
and objectively derived.” But Peter Doshi argues that in the case of influenza vaccinations and their
marketing, this is not so.
by Peter Doshi postdoctoral fellow
Johns Hopkins University School of Medicine, Baltimore, Maryland

bmj.f3037.full

 

To your health,

Elena

Recommended Posts
Showing 2 comments
pingbacks / trackbacks

Leave a Comment